The overall goal of the Cancer Training Program (CTP) is to develop programs that will facilitate both faculty and graduate student training and career development In cancer research. Specifically, we will: 1) Implement a 12-month Health Disparities Research Training Program (HDRTP) targefing post-doctoral fellows and junior faculty with three career training tracks (Community-Based Participatory Research, Cancer Control and Populafion Science, and Basic Science in Cancer Research);2) Implement a Summer Cancer Research Training Program (SCRTP) targeting graduate students, to introduce students to the cancer research field and provide them with basic knowledge about cancer health disparities and methods to address these disparities; 3) Provide extended training to graduate students who have excelled in the SCRTP through the implementation of a year-long Cancer Research Fellows Program;and 4) Improve the integration of all levels of training (graduate students, post-doctoral fellows, and faculty) and promote the CTP as a professional development resource through a Web-based Resource Center, Alumni Program, and symposia.

Public Health Relevance

The Cancer Training Program (CTP) is highly relevant to the objecfives ofthe Partnership. One ofthe priorities ofthe Partnership is to develop a cadre of well-trained investigators who will seek to understand the root causes of cancer disparifies among racial/ethnic minorifies and socioeconomically disadvantaged populations and test strategies to address and eliminate these disparities. By targeting three levels of cancer research investigators?graduate students; post-doctoral fellows; and faculty (including junior faculty and transitional faculty)?the Training Program aims to increase the number of minority investigators engaged in cancer research as well as the number of non-minority investigators engaged in cancer research with minority and socioeconomically disadvantaged populations. Through this work; we strive to make cancer disparities history and improve the health of minorities and disadvantaged populafions throughout the Southeast and the nafion. The CTP is critical component integrated with the Partnership's other programs. It links with the Cancer Research Proqram throuah the training of junior pilot project invesfigators; facilitafing their career development; and offering them seminars and scholarly enrichment events. CTP scholars and students have the opportunity to work on community-based research projects through the Cancer Outreach Prooram. The CTP integrates the Bioethics Shared Resource and the Biostatisfics Shared Resource into its training components. By providing workshops and online courses in these two areas and emphasizing the importance bioethics and biostafisfics in lectures and discussions; the CTP develops greater awareness of how bioethics impacts research decisions and acfions; and how crifical biostatistics is throughout the research process. The CTP is also linked with the Cancer Education Program through the courses at TU; namely Foundations of Cancer Biology; Biosciences Research and Ethics (both established and implemented underthe P20 grant); and the Health Disparifies course launched in 2007-2008 school year. At MSM; a cancer track existed in the Preventive Medicine Residency program. During the proposed funding period; other graduate students at MSM (MPH; MSCR; and MD) will have access to cancer education through a recently developed; NCI R25-funded curriculum. Thus the CTP works together with all programs and cores in a cohesive effort to reach the overall Partnership goals.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Tuskegee University
United States
Zip Code
Chen, Ina; Mathews-Greiner, Lesley; Li, Dandan et al. (2017) Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med 15:92
Piyathilake, Chandrika J; Badiga, Suguna; Borak, Samuel G et al. (2017) A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 9:413-420
Afolabi, Michael O S; Sodeke, Stephen O (2017) Reconciling Competence and Consent in Opioid-Dependence Research: The Value of Vulnerability Rhetoric. Am J Bioeth 17:48-50
Ahmed, Md Shakir Uddin; Salam, Ahmad Bin; Yates, Clayton et al. (2017) Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer. Int J Nanomedicine 12:6973-6984
Williams, Samuel K; Braxton, Joanne M; Gosdin, Melissa et al. (2017) Evidence-Based Care for the Elderly: Uses of ""the Grandmother Principle"". J Health Care Poor Underserved 28:7
Gao, Song; Wang, Yicun; Wang, Meng et al. (2017) MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 8:41451-41464
Zhang, Guangxin; Zhang, Wei; Li, Bingjin et al. (2017) MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer. Breast Cancer Res 19:73
Afolabi, Michael O S; Sodeke, Stephen O (2017) A Multifaceted Approach Is Needed to Respond to the Plight of Bioethicists in Accessing Literature. Am J Bioeth 17:37-39
Zhang, Yifan; Li, Bingjin; Zhang, Xingyi et al. (2017) CD24 is a genetic modifier for risk and progression of prostate cancer. Mol Carcinog 56:641-650
Sodeke, Stephen O; Wilson, Wylin D (2017) Integrative Bioethics is a Bridge-Builder Worth Considering to Get Desired Results. Am J Bioeth 17:30-32

Showing the most recent 10 out of 129 publications